KT&G Accelerates Overseas Expansion Through ESSE and RAISON Brands

Jan.06
KT&G Accelerates Overseas Expansion Through ESSE and RAISON Brands
KT&G accelerates overseas expansion with "ESSE" and "RAISON" brands, expecting 50% profit growth in 2024.

According to N.News on January 5th, South Korean tobacco company KT&G is accelerating its expansion in overseas markets through its cigarette brands "ESSE" and "RAISON." In the third quarter of 2024, KT&G's sales in the overseas tobacco market reached 419.7 billion Korean won, an increase of 30.5% compared to the previous year. It is expected that the overseas business profits of cigarettes and e-cigarettes will increase by approximately 50% in 2024.


KT&G pointed out that its key growth came from increased sales of the ultra-slim cigarette brands "ESSE," "RAISON," and "Bohem," with particular strong performance in the Indonesian market. In 2023, sales of "ESSE" in Indonesia reached 9.6 billion units. The flagship product "ESSE Berry Pop," which was launched in 2017, has been very popular, with sales reaching 205 million units within just one year of its launch.


In addition, in the Mongolian market, KT&G has surpassed Japan Tobacco International (JTI) to take the lead in market share. In 2023, their market share exceeded 50%, making it the first country where the company's market share overseas has exceeded 50%. The export volume has also increased from 300 million in 2011 to 2.35 billion in 2023, an increase of approximately 7.8 times.


KT&G is also expanding its presence in the European market. In 2024, the company launched two new "ESSE" products in Romania and entered the markets of Spain and Portugal. In Kazakhstan, KT&G ranks third in market share, while it holds the top position in Tajikistan.


Benefiting from the strong performance of its overseas business, KT&G plans to establish localized production facilities. The company is constructing a new factory in Surabaya, East Java Province, Indonesia, covering an area of 190,000 square meters. It is scheduled to be completed in 2026 with an annual production capacity of up to 21 billion cigarettes. Additionally, a plant of approximately 200,000 square meters in Almaty, Kazakhstan is also set to begin production in 2026.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Non-Nicotine Smoking Cessation Drug Cytisinicline Submitted for FDA Review
Non-Nicotine Smoking Cessation Drug Cytisinicline Submitted for FDA Review
Cytisinicline has been submitted for FDA approval and, if approved, would become the first non-nicotine smoking cessation drug in 20 years.
Jul.07 by 2FIRSTS.ai
Brazil Study: 11% of Teenagers Use E-Cigarettes, Consumption Rate Five Times Higher than Traditional Cigarettes
Brazil Study: 11% of Teenagers Use E-Cigarettes, Consumption Rate Five Times Higher than Traditional Cigarettes
A survey by the Federal University of São Paulo reveals 11% of teens (14+) use e-cigarettes, five times the rate of traditional cigarettes. Despite a ban, easy online access and higher nicotine content lead to misuse, reversing progress made by 1990s anti-smoking policies.
Jun.23 by 2FIRSTS.ai
U.S. Convenience Store Association Urges Trump Administration: Expedite Product Approvals, Strengthen Enforcement, Crack Down on Illegal Chinese E-Cigarettes
U.S. Convenience Store Association Urges Trump Administration: Expedite Product Approvals, Strengthen Enforcement, Crack Down on Illegal Chinese E-Cigarettes
The National Association of Convenience Stores (NACS) and four major retail groups urged the Trump administration to curb illegal Chinese e-cigarettes, citing heavy losses for compliant retailers. They called on the FDA to speed up product approvals and push for stricter customs checks and DOJ prosecutions.
Jul.21 by 2FIRSTS.ai
From Combustion to Conversation: BAT’s Omni Platform Tackles Misconceptions About Nicotine — A 2Firsts Exclusive Interview
From Combustion to Conversation: BAT’s Omni Platform Tackles Misconceptions About Nicotine — A 2Firsts Exclusive Interview
Launched in 2024, BAT’s Omni platform aims to advance tobacco harm reduction, dispel misconceptions about nicotine, and accelerate the transition to a smokeless future through science. In this 2Firsts exclusive interview, BAT’s head of strategic and digital communications shares insights on Omni’s vision and global impact.
Jul.15
Tobacco Giants Speak on THR at GFN: Calling for Regulatory Reform Aligned with Scientific Understanding
Tobacco Giants Speak on THR at GFN: Calling for Regulatory Reform Aligned with Scientific Understanding
At the GFN 2025, representatives from the world’s four largest tobacco companies emphasized the need for science-driven harm reduction policies. They urged regulators to move beyond outdated approaches and adopt consumer-focused, evidence-based frameworks to better serve public health goals.
Jun.26
Malaysian Authorities Seize $30,000 Worth of Vape Products; 43-Year-Old Man Under Investigation
Malaysian Authorities Seize $30,000 Worth of Vape Products; 43-Year-Old Man Under Investigation
Malaysian GOF seized 1,242 bottles of vape liquid and 36 boxes of devices worth RM125,000 ($30,000) in Tanah Merah. A 43-year-old man is under investigation for lacking valid documents and storage permits. The case is being processed under MDTM regulations.
Jul.23 by 2FIRSTS.ai